BioSpace News Archive

Drug Development

Gilead Sciences, Inc. Announces Phase 2 Results for Sofosbuvir-Based Regimens in Hepatitis C Patients Before and After Liver Transplantation

November 4, 2013
·
1 min read
Drug Development

Nuvilex Announces Cloning of Cells for Future Phase 3 Clinical Trials Initiated by Inno Biologics

November 4, 2013
·
4 min read
BioMidwest

EnteroMedics to Participate in Fireside Chat at the Canaccord Genuity Medical Technologies & Diagnostics Forum

November 4, 2013
·
4 min read
arGEN-X Raises EUR 5 Million From PMV in Extension of EUR 32.5 Million Series B

November 4, 2013
·
2 min read
Winners of the First-Ever Nanomedicine Award Revealed at BIO-Europe

November 4, 2013
·
6 min read
Drug Development

Presidio Pharmaceuticals, Inc. Announces a High Rate of Virologic Response in an Ongoing Phase 2 Hepatitis C Trial of a New All-Oral Combination of Presidio’s PPI-668 With Boehringer Ingelheim Corporation’s Faldaprevir and Deleobuvir

November 4, 2013
·
8 min read
Genetown

Enanta Pharmaceuticals, Inc. Release: New GT-1b Data From ABT-450 Containing Regimen Being Presented at The Liver Meeting

November 4, 2013
·
4 min read
Genetown

PCI Synthesis Wins Four 2013 CMO Leadership Awards

November 4, 2013
·
2 min read
Biotech Bay

NeuroSky Secures Strategic Investment From SoftBank Corp. to Accelerate the Development of Advanced Mobile Health and Wellness Solutions

November 4, 2013
·
1 min read
Pharm Country

The Jackson Laboratory Release: JAX® Mice Headed for Space

November 4, 2013
·
1 min read